OABI FY 2025 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M-29.3% YoY

Gross Profit

$18M98.4% margin

Operating Income

-$3M-13.7% margin

Net Income

-$65M-347.0% margin

EPS (Diluted)

$-0.57

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$301M

Total Liabilities

$34M

Stockholders' Equity

$267M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$26M	-29.3%
Gross Profit	$18M	$26M	-30.4%
Operating Income	-$3M	-$75M	+96.6%
Net Income	-$65M	-$62M	-4.4%